CoStar Group (NASDAQ: CSGP) to buy Zonda for $800M in cash, adding new home data and marketplaces
Rhea-AI Filing Summary
CoStar Group plans to expand further into new home real estate by acquiring Zonda, a leading new home construction data and marketplace business, for $800 million in cash. Zonda serves more than 3,000 homebuilding ecosystem customers and generates mostly subscription revenue with 104% net customer retention, indicating strong stickiness.
The deal is expected to close in the second half of 2026, subject to Hart-Scott-Rodino and other regulatory clearances and customary conditions, including no material adverse effect at Zonda. CoStar expects the acquisition to be accretive to adjusted EPS in the first full year of ownership and to create cross-sell opportunities across its commercial, residential, multifamily, lending, and analytics businesses.
Positive
- Strategic expansion into new home sector: CoStar is acquiring Zonda for $800 million in cash, adding a leading new home data, software, and marketplace platform that management expects to be accretive to adjusted EPS in the first full year of ownership.
Negative
- None.
Insights
$800M Zonda acquisition deepens CoStar’s presence in new home data and marketplaces.
CoStar Group is committing $800 million in cash to buy Zonda, which provides new home construction data, software, and marketplaces such as NewHomeSource and Livabl. Zonda’s predominantly subscription model and 104% net customer retention suggest durable, recurring revenue with embedded customer relationships.
The acquisition extends CoStar’s coverage into a large adjacent sector; the release cites U.S. new residential construction approaching $1 trillion annually. Management states the deal is expected to be accretive to adjusted EPS in the first full year, but this depends on closing, integration execution, and maintaining Zonda’s margins and retention.
Closing is targeted for the second half of 2026 and remains subject to Hart-Scott-Rodino and other regulatory approvals, absence of a material adverse effect, and other customary conditions. There is an outside termination date of May 28, 2027, highlighting potential timing and regulatory uncertainty until approvals are obtained and integration begins.